CBD – Cannabidiol – Medical Cannabis Doctors Australia

Category: CBD – Cannabidiol

image
16 July

Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample Sinikka L. Kvamme, Michael M. Pedersen, Kristine Rømer Thomsen & Birgitte Thylstrup   Background The use of cannabis as medicine (CaM) both prescribed and non-prescribed has increased markedly in the last decade, mirrored in a global shift in cannabis policy […]

Read More
image
13 July

Proportion of Prescribed Conditions & Latest Patient Approval Numbers To date, the TGA has approved SAS applications including, but not limited to, the following indications: chemotherapy-induced nausea and vomiting refractory paediatric epilepsy palliative care indications cancer pain neuropathic pain spasticity from neurological conditions anorexia and wasting associated with chronic illness (such as cancer) A break […]

Read More
image
01 June

The long-term efficacy of cannabidiol in the treatment of refractory epilepsy Cannabidiol (CBD) has been shown to reduce seizures among patients with refractory epilepsies of various etiologies in recent clinical trials and an expanded access program (EAP). Most studies report efficacy over short time periods (<1 year), with little published on longer term efficacy. Here, […]

Read More
image
09 May

UK CBD Sales Surge   Research from two industry pressure groups reveals the UK cannabinoid (CBD) industry was worth £690mln in the 12 months to the end of April – up almost a third since a 2019 estimate. CBD is the non-psychoactive element derived from both marijuana and hemp plants. It is used in an […]

Read More
image
02 May

Epidyolex added to PBS for Dravet Syndrome Press conference about a new treatment on the PBS and Phase 2A of the COVID-19 vaccine rollout Read the transcript of the press conference with Minister Hunt at the Star Health GP Respiratory Clinic at the Prahan Townhall in Melbourne on 30 April about a new treatment for […]

Read More
image
12 April

Medical Cannabis: where are we at? This is a fantastic article by respected experts Associate Professor Vicki Kotsirilos AM was Australia’s first authorised GP prescriber of medicinal cannabis in May 2018. Professor Iain S McGregor is the Academic Director of the Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney’s Brain and Mind Centre. […]

Read More
image
15 December

TGA allows OTC sales of Cannabidiol The medical cannabis industry took a big step forward in Australia today with the announcement from the regulator. The Therapeutic Goods Administration or TGA has announced it will down-schedule cannabidiol (CBD) in low dose preparations from Schedule 4 (defined as prescription medications) to Schedule 3 available in pharmacies. According […]

Read More